T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy

Journal of Clinical Oncology

Volumn 19, Issue 20, 2001, Pages 4029-4036

  Mendenhall, W M ^a   Amdur, R J ^a   Morris, C G ^a   Hinerman, R W ^a  

^a Department of Radiation Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; GLOTTIS; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0035887302     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.20.4029     Document Type: Article

References (42)

1. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: Relationship of dose-fractionation factors to local control and complications
2. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery
3. Results of curative laser microsurgery of laryngeal carcinomas
4. Squamous cell carcinoma of the glottic larynx: A review emphasizing the University of Florida philosophy
5. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx
6. Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer?
7. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck
8. A multimodal strategy for the treatment of patients with T 2 invasive squamous cell carcinoma of the glottis
9. Laryngofissure and cordectomy for early cordal carcinoma: Outcome in 182 patients
10. Hemilaryngectomy for T2 glottic cancer
11. Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck
12. Larynx
13. The influence of dose and time on wound complications following post-radiation neck dissection
14. Nonparametric estimation from incomplete observations
15. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: A multivariate analysis of variables potentially influencing local control
16. Influence of fraction size, total dose, and overall time on local control of T1-T 2 glottic carcinoma
17. T1-T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control
18. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx
19. p53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer
20. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis
21. Does prolonged treatment course adversely affect local control of carcioma of the larynx?
22. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer
23. The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis
24. Radiation therapy for T1,2 glottic carcinoma: Impact of overall treatment time on local control
25. Does waiting time affect the outcome of larynx cancer treated by radiotherapy?
26. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers
27. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: A linear quadratic analysis
28. The effect of fraction size on control of early glottic cancer
29. Early-stage glottic cancer: Importance of dose fractionation in radiation therapy
30. Impact of radiation therapy fraction size on local control of early glottic carcinoma
31. Radiotherapy of T1 glottic cancer with 6 MeV X rays
32. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
33. Radiation therapy for glottic cancer using 6-MV photons
34. 60Co versus 6 MV photons
35. Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx?
36. Radiation therapy for early glottic cancer (T1N0M0): II. Prospective randomized study concerning radiation field
37. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck
38. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer: Report of 3-year tumour control and normal tissue toxicity